Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value: $238M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ADAMAS PHARMACEUTICALS INC | 1,437,335 | $40.7M | 17.1% | $20.76 | — | COM | 00548A106 |
| — | FIVE PRIME THERAPEUTICS INC | 569,658 | $23.64M | 9.9% | $20.62 | — | COM | 33830X104 |
| — | ZOGENIX INC | 1,414,927 | $20.86M | 8.8% | $13.55 | — | COM NEW | 98978L204 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,100,101 | $19.55M | 8.2% | $11.18 | -10.8% | COM | 921659108 |
| — | TETRAPHASE PHARMACEUTICALS I | 1,940,000 | $19.46M | 8.2% | $8.55 | — | COM | 88165N105 |
| — | CONNECTURE INC | 4,127,232 | $14.9M | 6.3% | $9.01 | — | COM | 20786J106 |
| — | ALCOBRA LTD | 2,012,622 | $12.64M | 5.3% | $5.99 | — | SHS | M2239P109 |
| EXEL | EXELIXIS, INC | 2,032,494 | $11.46M | 4.8% | $5.47 | +2.2% | COM | 30161Q104 |
| — | SYNERGY PHARMACEUTICALS DEL | 1,546,888 | $8.771M | 3.7% | $7.60 | — | COM NEW | 871639308 |
| — | SUNESIS PHARMACEUTICALS INC | 8,250,000 | $7.404M | 3.1% | $1.47 | — | COM NEW | 867328601 |
| — | GW PHARMACEUTICALS PLC | 100,000 | $6.944M | 2.9% | — | — | Put | 36197T103 |
| — | PARATEK PHARMACEUTICALS INC | 355,459 | $6.743M | 2.8% | $25.19 | — | COM | 699374302 |
| — | RAPTOR PHARMACEUTICAL CORP | 1,282,527 | $6.669M | 2.8% | $6.05 | — | COM | 75382F106 |
| AUPH | AURINIA PHARMACEUTICALS INC | 2,457,144 | $6.16M | 2.6% | $3.52 | -23.0% | COM | 05156V102 |
| — | OCERA THERAPEUTICS INC | 1,963,777 | $6.127M | 2.6% | $6.20 | — | COM | 67552A108 |
| — | BOVIE MEDICAL CORP | 2,680,000 | $5.628M | 2.4% | $2.72 | — | COM | 10211F100 |
| VCEL | VERICEL CORP | 2,086,028 | $5.382M | 2.3% | $2.85 | -21.5% | COM | 92346J108 |
| — | ARADIGM CORP | 1,002,962 | $3.982M | 1.7% | $8.85 | — | COM NO PAR NEW | 038505400 |
| — | TENAX THERAPEUTICS INC | 1,108,593 | $3.636M | 1.5% | $3.93 | — | COM | 88032L100 |
| — | CALADRIUS BIOSCIENCES INC | 2,248,781 | $2.429M | 1.0% | $1.87 | — | COM | 128058104 |
| — | TRANSITION THERAPEUTICS INC | 856,602 | $1.645M | 0.7% | $1.85 | — | COM NEW | 893716209 |
| — | FLEXION THERAPEUTICS INC | 78,100 | $1.505M | 0.6% | — | — | Call | 33938J106 |
| CYTK | CYTOKINETICS INC | 106,800 | $1.117M | 0.5% | — | — | Put | 23282W605 |
| — | MANNKIND CORP | 503,000 | $729K | 0.3% | — | — | Put | 56400P201 |
| — | STREAMLINE HEALTH SOLUTIONS | 151,611 | $214K | 0.1% | $6.45 | — | COM | 86323X106 |